secwatch.observer — SEC 8-K summary
======================================

Issuer:     Eloxx Pharmaceuticals, Inc. (ELOX)
CIK:        0001035354
Form:       8-K
Filed at:   2023-08-03T23:59:59+00:00
Accession:  0001104659-23-087248
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Eloxx receives Nasdaq extension to Oct 9, 2023 to meet $35M market value rule
-----------------------------------------------------------------------------

- Nasdaq Hearings Panel extended compliance deadline for Listing Rule 5550(b)(2) from July 30 to October 9, 2023.
- Company must maintain at least $35 million market value of listed securities to avoid delisting.
- Extension follows a May 18, 2023 hearing and a July 27, 2023 request by Eloxx.
- Failure to regain compliance by October 9 could result in delisting from Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1035354/000110465923087248/0001104659-23-087248-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1035354/000110465923087248/tm2322789d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-087248

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer